A lateral flow “Point of Care” drug test device/kit is a competitive binding, lateral flow immunochromatographic assay for qualitative and simultaneous detection of drugs of abuse in human urine or oral fluid specimens. The test devices/kits usually consist of one or more membrane strips mounted in a plastic cassette/device. A bit like a pregnancy test – they give an indication via a marker which is interpreted as either a “Negative” or “Positive” screen result. This initial “screen” result is never 100% accurate and requires further (more expensive) confirmation analysis. This result can only be quantified via laboratory confirmatory analysis. ITS would recommend that this was carried out via a UKAS accredited laboratory.
Charity Alcohol Change UK have announced Alcohol Awareness Week (AAW) 2019 will take place from 11-17 November. Are you / your workplace doing anything to support and promote Alcohol Awareness Week?
Pregabalin and Gabapentin to be controlled as class C drugs from April 2019 Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from April 2019, the government announced on 15 October 2018.The move comes after experts highlighted rising numbers of fatalities linked to the drugs. The change means it will be illegal to possess pregabalin and gabapentin without a prescription and it will be illegal to supply or sell them to others.
Official figures show that drug deaths have risen sharply in England and Wales, reaching record numbers last year. A total of 4,359 people died due to drug poisoning last year, this includes accidental overdoses and suicides from medicinal drugs, as well as illicit drug use.